Articles Archives - Page 488 of 825

FridayJul 09, 2021 10:52 am

FingerMotion Inc. (FNGR) Continues to Push the Envelope in the Insurance Industry with Latest Subsidiary Partnership

FingerMotion’s subsidiary Xunlian Tianxia Technology entered into an agreement with Happy Life Insurance to create an innovative, data-driven insurance business model The model aims to develop new insurance products that can address real consumers’ needs by combining Xunlian’s data mining and customer profiling experience with Happy Life’s insurance expertise The new collaboration follows a similar announcement earlier this year in which FingerMotion partnered with Pacific Life Re-Insurance FingerMotion expects multiple contracts relating to its insurtech products before the end of calendar 2021 New technologies such as big data, blockchain, the Internet of Things (“IoT”), artificial intelligence (“AI”), and cloud computing…

FridayJul 09, 2021 10:27 am

Emaginos Inc. Files Patent for Exclusive Educational Analytics Platform

Company files provisional patent for EdManage Analytics Platform with US patent office EdManage carefully aggregates individual parts into new entity that provides insightful, useful and actionable information Emaginos believes its EdManage system has potential to make a profound impact on education Emaginos, a REG-A public company (please see website if interested in investing) in the business of transforming K-12 public education, has filed a patent for its EdManage Analytics Platform (https://ibn.fm/EzYJ5). Emaginos announced earlier this month that it had filed a provisional patent application, titled “Education Analytics Platform,” with the United States Patent and Trademark Office for its proprietary analytics…

ThursdayJul 08, 2021 1:00 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company

Jazz Pharmaceuticals’ acquisition of GW Pharma for $7.2 billion in February 2021 shows the massive potential of the drug development industry from naturally-derived compounds Tryp Therapeutics is following in the footsteps of GW with its innovative drug pipeline and the development of psilocybin-based compounds for the treatment of diseases with high unmet medical needs It is one of only a handful of companies moving into Phase 2a clinical trials with a psychedelic compound, and seeks to duplicate the success of GW As of 2020, the global biotech sector was valued at $753 billion. It is further projected to grow at…

ThursdayJul 08, 2021 12:38 pm

Infobird Co., Ltd (NASDAQ: IFBD) and its Influence on China’s SaaS Market

SMEs account for about 60% of China’s production GDP However, they have a relatively low adoption of SaaS and automation tools Infobird, through innovation and education, is trying to rectify this issue By targeting these SMEs, it will be impacting the entire Chinese SaaS market, positioning it as a global leader As of 2019, the Chinese software-as-a-service SaaS market was estimated between $3.7 billion and $6 billion in value (https://ibn.fm/NBymg). That was just 6% less than the total value of the global SaaS market. This is great for the country. However, when compared to other nations such as the United…

ThursdayJul 08, 2021 11:38 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology

Lexaria Bioscience Corp. announced positive results from its VIRAL-A20-2 study This study showed strong gains in delivery of the DehydraTECH-enabled remdesivir and ebastine among animals The success of this study shows the potential and commercial viability of Lexaria’s DehydraTECH In June 2021, Lexaria Bioscience (NASDAQ: LEXX) announced positive results from its VIRAL-A20-2 study that evaluated the effectiveness of DehydraTECH-enabled remdesivir and ebastine among animals. The results were strongly positive and demonstrated greater effectiveness than in Lexaria’s first antiviral drug study reported in December 2000. The research was a tolerability and pharmacokinetic (“PK”) study involving four groups of 10 animals each.…

ThursdayJul 08, 2021 10:58 am

Friendable Inc.’s (FDBL) Fan Pass Platform Providing Added Value, Revenue-Generating Opportunities in Music Streaming Industry

Friendable’s Fan Pass platform has provided revenue streams for artists that may not have existed due to the global pandemic Version 2.0 of the Fan Pass artist streaming platform to be released on July 24, 2021, which also marks the first anniversary of the platform Friendable has signed a Letter of Intent for the production of musical-artist NFTs and the creation of a “Fanpasscrypto” marketplace The global music streaming market was valued at $24.4 billion in 2020 and is expected to grow by a CAGR of 17.8%, resulting in $76.9 billion in revenue by 2027 (https://ibn.fm/v0NFs). The increase is largely…

WednesdayJul 07, 2021 12:35 pm

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Seals Tier 1-level Contract for Ongoing March of Company’s Technology in The Marketplace

E-commerce and conferencing evolution platform developer Nextech AR Solutions has sealed a contract with a multinational company that has been listed as one of Fortune magazine’s World’s Most Admired Companies over consecutive years Nextech also recently announced its acquisition of artificial intelligence innovator Threedy.ai, Inc., which has developed a platform for mass producing 3D images for retailers The developments advance Nextech’s opportunities to acquire recurring revenue based on its proprietary LiveX platform The global AR market is expected to grow at a CAGR of 43.8 percent by 2028 to $340.16 billion in annual revenues An agreement announced July 6 between…

WednesdayJul 07, 2021 11:56 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Positioning Itself to Compete in US Functional Beverage Market

“Forbes” article notes that $20 million Naturo Group acquisition creates ideal situation for BevCanna expansion BevCanna boasts one of most unique, diverse portfolios of beverage and natural health products within both cannabis, plant-based industries Combination of two Canadian beverage industry leaders unlocks significant potential for growth As Canadian cannabis company BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) expands its infused functional beverage business into the United States, its deliberate, transformative strategy has garnered a mention in a recent “Forbes” article. Titled “BevCanna Expands in the U.S. Infused Functional Beverage Market Upon Acquiring Naturo Group,” the article noted that the…

WednesdayJul 07, 2021 10:41 am

Ideanomics Inc.’s (NASDAQ: IDEX) Dr. Abas Goodarzi Feted for Contributions to the Advancement of Electric Powertrains for Medium and Heavy-Duty Vehicles

Ideanomics Chief Scientist and CEO of US Hybrid Dr. Abas Goodarzi recently received the 2021 IEEE PELS Vehicle and Transportation System Achievement Award for his contributions to the advancement of electric powertrains for medium and heavy-duty vehicles Dr. Abas is a 38-year veteran in the electric, hybrid, and fuel cell industries Prior to his role at Ideanomics, he had worked as an Associate professor at California State University, San Francisco, and later as a Technical Director at General Motors and Senior Scientist at Hughes Aircraft Company Ideanomics (NASDAQ: IDEX) recently announced that its Chief Scientist and US Hybrid CEO, Dr.…

WednesdayJul 07, 2021 10:25 am

Predictive Oncology Inc. (NASDAQ: POAI) Companies Build New Labs, Expand Services for New Drug Discoveries

Two of Predictive Oncology’s four subsidiaries are constructing new Good Manufacturing Practices laboratories to offer additional services to customers With its new GMP lab, Soluble Biotech will provide customers formulations that can go directly to clinical trials, as well as manufacture proprietary media used in its chromatography kits TumorGenesis will use its GMP lab to produce its proprietary media that tricks tumor cells into growing outside the body the same as inside the body in addition to producing proteins and other biological products used in diagnosing, treating, and modifying tumor cells On the heels of raising $21.34 million and three…

Site Search

Company Search

Category: Articles